Eyenovia Inc

0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)72.10M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.31 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$1.68
50-Day MA$1.91
200-Day MA$2.67
See more pivots

Eyenovia Inc Stock, NASDAQ:EYEN

295 Madison Avenue, Suite 2400, New York, New York 10017
United States of America
Phone: +1.917.289.1117
Number of Employees: 41


Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.